Evidence map›Paper›PMID 40982152›Full record

ArticleAnnals of surgical oncology2026

Segmental Resection of the Inferior Vena Cava is Safe and Feasible for Patients with Renal Cell Carcinoma with Tumor Thrombus: A Large-Scale Retrospective Study from a High-Volume Center.

Le Yu, Weiliang Zhang, Peichen Duan, Fan Zhang, Shaohui Deng, Ye Yan, Zhou Liu, Yimeng Song, Guoliang Wang, Hongxian Zhang and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Le Yu *Department of Urology, Peking University Third Hospital, Haidian District, Beijing, People's Republic of China.
Weiliang Zhang *Department of Urology, Peking University Third Hospital, Haidian District, Beijing, People's Republic of China.
Peichen Duan *Department of Urology, Peking University Third Hospital, Haidian District, Beijing, People's Republic of China.
Fan ZhangDepartment of Urology, Peking University Third Hospital, Haidian District, Beijing, People's Republic of China.
Shaohui DengDepartment of Urology, Peking University Third Hospital, Haidian District, Beijing, People's Republic of China.
Ye YanDepartment of Urology, Peking University Third Hospital, Haidian District, Beijing, People's Republic of China.
Zhou LiuDepartment of Urology, Peking University Third Hospital, Haidian District, Beijing, People's Republic of China.
Yimeng SongDepartment of Urology, Peking University Third Hospital, Haidian District, Beijing, People's Republic of China.
Guoliang WangDepartment of Urology, Peking University Third Hospital, Haidian District, Beijing, People's Republic of China.
Hongxian ZhangDepartment of Urology, Peking University Third Hospital, Haidian District, Beijing, People's Republic of China.
Peng HongDepartment of Urology, Peking University Third Hospital, Haidian District, Beijing, People's Republic of China. hppkusteven@163.com.ORCID http://orcid.org/0000-0002-3028-8872
Shudong ZhangDepartment of Urology, Peking University Third Hospital, Haidian District, Beijing, People's Republic of China. zhangshudong@bjmu.edu.cn.

Funding

Clinical Cohort Construction Program of Peking University Third Hospital BYSYDL2021023National Natural Science Foundation of China 82072828Natural Science Foundation of Beijing Municipality 7232212
6 · The paper itself

Abstract

purposeWe aimed to evaluate perioperative and oncological outcomes in renal cell carcinoma (RCC) with tumor thrombus (TT) patients undergoing inferior vena cava (IVC) segmental resection, with comparative analysis stratified by surgical approaches.

methodsA retrospective analysis was conducted on 271 RCC with TT patients. Patients' clinicopathological data were collected. Continuous variable comparisons utilized the Wilcoxon rank-sum test or unpaired t-tests based on their distribution, while categorical variable analyses employed the Chi-square test. Survival outcomes were evaluated through Kaplan-Meier estimation.

resultsOverall, 123 patients (45.4%) experienced IVC segmental resection. Despite exhibiting poorer preoperative renal function, the segmental resection group achieved comparable postoperative estimated glomerular filtration rate (eGFR) as the control group (56.7 vs. 55.7 mL/min/1.73m

conclusionSegmental resection of the IVC represents a safe and technically feasible intervention in RCC patients with TT, demonstrating acceptable perioperative safety in appropriately selected cases. Robot-assisted techniques significantly reduced procedural complexity and optimized perioperative outcomes.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsNephrectomyRobotic Surgical ProceduresThrombectomyVena Cava, InferiorVenous ThrombosisAdultAgedFeasibility StudiesFemaleFollow-Up StudiesGlomerular Filtration RateHospitals, High-VolumeHumansLength of StayOncological outcomePerioperative outcomeRenal cell carcinomaSegmental resectionTumor thrombus

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.